Characterization of NPC1-I1061T proteostasis machinery for development of NPC therapeutics

Awardee: Andrew Lieberman

Institution: University of Michigan

Award Amount: $53,000

Funding Period: January 1, 2016 - December 31, 2016

Previous
Previous

Exploring the impact of a TCF4 mutation on the physiology of inhibitory neurons of the prefrontal cortex.

Next
Next

MITF as a driver oncogene and therapeutic target in angiomyolipoma/LAM